Main Article Content
chronic eczema, pruritus, Zanthoxylum bungeanum, Zanthoxylum schinifolium, volatile oil
Objective: To observe the antipruritic effect and mechanism of the volatile oil of Zanthoxylum bungeanum and Zanthoxylum schinifolium on chronic eczema to provide data support for clinical application and new drug development of Zanthoxylum bungeanum and Zanthoxylum schinifolium.
Methods: The model of chronic eczema was established by using 2-dinitrochlorobenzene (DNCB), and the composition and content of volatile oil in Zanthoxylum schinifolium and Zanthoxylum bungeanum was determined by gas chromatography-mass spectrometry (GC-MS). The antipruritic effect by (EASI) score of eczema area and severity index and scratching times was then evaluated. Then, the contents of histamine, gastrin-releasing peptide (GRP), interleukin-4 (IL-4), and immunoglobulin E (IgE) in serum of rats was determined by enzyme-linked immunosorbent assay (ELISA). The tissue morphology was observed by HE staining. The expressions of H1R, PAR-2, TRPV1, TRPA1, and GRPR was then detected by immunohistochemistry, Western blot, and QRT-PCR.
Results: The results revealed that there were differences in the composition of volatile oil between Zanthoxylum bungeanum and Zanthoxylum schinifolium. Compared to the model group, the medium-dose group of Zanthoxylum bungeanum and Zanthoxylum schinifolium group significantly increased the difference of EASI score and scratching times, significantly decreased the concentrations of IL-4, IgE, GRP, and histamine, and significantly decreased the expression levels of H1R, PAR-2, TRPV1, and GRPR. The degree of inhibition on the pathological manifestations of chronic eczema was evident. There was no significant difference in antipruritic effect between the two groups. The expression of TRPA1 was inconsistent at the protein and gene level, which needs to be further researched.
Conclusion: The volatile oil of Zanthoxylum bungeanum and Zanthoxylum schinifolium can reduce the expression of H1R, PAR-2, TRPV1, and GRPR. The mechanism may be through the H1R and PAR-2-mediated GRPR pathway intervention to achieve the effect, both of which have the same antipruritic effect.
2. Tsai TF, Rajagopalan P, Chu CY, Encarnacion L, Gerber RA, Santos-Estrella P, et al. Burden of atopic dermatitis in Asia. J Dermatol. 2019;46:825–834. 10.1111/1346-8138.15048
3. Cheng J, Wu JJ, Han G. Epidemiology and Characterization of Atopic Dermatitis in East Asian Populations: A Systematic Review. Dermatol Ther (Heidelb). 2021;11(3):707–717. 10.1007/s13555-021-00516-w
4. Arima, K, Gupta S, Gadkari A, Hiragun T, Kono T, Katayama I, et al. Burden of atopic dermatitis in Japanese adults: Analysis of data from the 2013 National Health and Wellness Survey. J Dermatol. 2018;45:390–396. 10.1111/1346-8138.14218
5. Erickson S., Nahmias Z, Rosman IS, Kim BS. Immunomodulating Agents as Antipruritics. Dermatol Clin. 2018;36:3253–34. 10.1016/j.det.2018.02.014
6. Yosipovitch G, Rosen JD, Hashimoto T. Itch: From mechanism to (novel) therapeutic approaches. Journal of Allergy and Clinical Immunology. 2018;142:13751–390. 10.1016/j.jaci.2018.09.005
7. Yosipovitch G, Bernhard JD. Clinical practice. Chronic pruritus. N Engl J Med. 2013;368(17):16251–634. 10.1056/NEJMcp1208814
8. Raveendran R. Tips and Tricks for Controlling Eczema. Immunol Allergy Clin North Am. 2019;39(4):5215–33. 10.1016/j.iac.2019.07.006
9. Lam TP. Strengths and weaknesses of traditional Chinese medicine and Western medicine in the eyes of some Hong Kong Chinese. J Epidemiol Community Health. 2001;55(10):7627–65. 10.1136/jech.55.10.762
10. Das A, Sil A, Das NK, Roy K, Das AK, Bandyopadhyay D. Acyclovir in pityriasis rosea: An observer-blind, randomized controlled trial of effectiveness, safety and tolerability. Indian Dermatol Online J. 2015;6(3):1811–84. 10.4103/2229-5178.156389
11. Vaughn AR, Clark AK, Sivamani RK, Shi VY. Natural Oils for Skin-Barrier Repair: Ancient Compounds Now Backed by Modern Science. Am J Clin Dermatol. 2018;19(1):1031–17. 10.1007/s40257-017-0301-1
12. Herman A, Herman AP. Essential oils and their constituents as skin penetration enhancer for transdermal drug delivery: a review. J Pharm Pharmacol. 2015;67(4):4734–85. 10.1111/jphp.12334
13. Zhang M, Wang J, Zhu L, Li T, Jiang W, Zhou J. Zanthoxylum bungeanum Maxim. (Rutaceae): A Systematic Review of Its Traditional Uses, Botany, Phytochemistry, Pharmacology, Pharmacokinetics, and Toxicology. Int J Mol Sci. 2017;18(10):2172. 10.3390/ijms18102172
14. Chinese Pharmacopoeia Committee. Pharmacopoeia of the people’s republic of China. Beijing: China Medical Science Press; 2020.
15. Chen P, Yang ZB, Yang GY, Yan CC, Zhan HM. Research Progress of traditional Chinese Medicine for external use in the treatment of chronic eczema. Chinese Archives of Traditional Chinese Medicine. 2012,30(03):523-526. Chinese.
16. Xia X. To evaluate the efficacy of treating chronic localized eczema with zanthoxylum oil. Hubei University of Traditional Chinese Medicine. 2017. Chinese.
17. Yang X. Aroma constituents and alkylamides of red and green huajiao (Zanthoxylum bungeanum and Zanthoxylum schinifolium). J Agric Food Chem. 2008;56(5):16891–696. 10.1021/jf0728101
18. Wan HL, Chen HZ, Shi XQ. Study on effect of Traditional Chinese Medicine Jianpi Chushi decoction and ointment on chronic eczema. Asian Pac J Trop Med. 2016;9(9):9209–23. 10.1016/j.apjtm.2016.07.019
19. Zhou M, Sui H. Effect of total glucosides of paeony on the changes of IL-4 and ICAM-1 levels in eczema mouse model serum. Exp Ther Med. 2019;17(3):15451–550. 10.3892/etm.2018.7122
20. Jegal J, Park NJ, Bong SK, Jegal H, Kim SN, Yang MH. Dioscorea quinqueloba Ameliorates Oxazolone-and 2,4-Dinitrochlorobenzene-induced Atopic Dermatitis Symptoms in Murine Models. Nutrients. 2017;9(12):1324. 10.3390/nu9121324
21. Lin Y, Han W, Ge WC, Yuan K. Chemical composition of the volatile oil from Zanthoxylum avicennae and antimicrobial activities and cytotoxicity. Pharmacogn Mag. 2014;10(Suppl 1):S1647–0. 10.4103/0973-1296.127369
22. Tine Y, Diop A, Diatta W, Desjobert JM, Boye CS, Costa J, et al. Chemical Diversity and Antimicrobial Activity of Volatile Compounds from Zanthoxylum zanthoxyloides Lam. according to Compound Classes, Plant Organs and Senegalese Sample Locations. Chem Biodivers. 2017;14(1). 10.1002/cbdv.201600125
23. Zhang W, Tan S, Xi W, Yang J, Liao Q, Lan J, et al. Comparison of volatile components in fresh and dried Zanthoxylum bungeanum Maxim. Food Sci Biotechnol. 2019;28(4):10831–092. 10.1007/s10068-019-00562-3
24. Mori HM, Kawanami H, Kawahata H, et al. Wound healing potential of lavender oil by acceleration of granulation and wound contraction through induction of TGF-β in a rat model. BMC Complement Altern Med. 2016;16:144. 10.1186/s12906-016-1128-7
25. Fujii M, Ohgami S, Asano E, Nakayama T, Toda T, Nabe T, et al. Brain allopregnanolone induces marked scratching behaviour in diet-induced atopic dermatitis mouse model. Sci Rep. 2019;9(1):2364. 10.1038/s41598-019-38858-3
26. Malin SA, Davis BM, Molliver DC. Production of dissociated sensory neuron cultures and considerations for their use in studying neuronal function and plasticity. Nat Protoc. 2007;2(1):1521–60. 10.1038/nprot.2006.461
27. Fan HJ, Zhao XS, Tan ZB, Liu B, Xu HL, Wu YT, et al. Effects and mechanism of action of Huang-Lian-Jie-Du-Tang in atopic dermatitis-like skin dysfunction in vivo and in vitro. J Ethnopharmacol. 2019;240:111937. 10.1016/j.jep.2019.111937
28. Boer K, Helinger E, Helinger A, Pocza P, Pos Z, Demeter P, et al. Decreased expression of histamine H1 and H4 receptors suggests disturbance of local regulation in human colorectal tumours by histamine. Eur J Cell Biol. 2008;87(4):2272–36. 10.1016/j.ejcb.2007.12.003
29. Materazzi S, Pellerito S, Di Serio C, Paglierani M, Naldini A, Ardinghi C, et al. Analysis of protease-activated receptor-1 and-2 in human scar formation. J Pathol. 2007;212(4):4404–49. 10.1002/path.2197
30. Lapin GA, Hochman B, Maximino JR, Chadi G, Ferreira LM. Effects of Lidocaine, Bupivacaine, and Ropivacaine on Calcitonin Gene-Related Peptide and Substance P Levels in the Incised Rat Skin. Adv Skin Wound Care. 2016;29(4):1691–77. 10.1097/01.ASW.0000480096.01724.91
31. Cevikbas F, Wang X, Akiyama T, Kempkes C, Savinko T, Antal A, et al. A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: Involvement of TRPV1 and TRPA1. J Allergy Clin Immunol. 2014;133(2):4484–60. 10.1016/j.jaci.2013.10.048
32. Cui YY, Xu H, Wu HH, Qi J, Shi J, Li YQ. Spatio-temporal expression and functional involvement of transient receptor potential vanilloid 1 in diabetic mechanical allodynia in rats. PLoS One. 2014;9(7):e102052. 10.1371/journal.pone.0102052
33. Kamakura T, Ishida Y, Nakamura Y, Yamada T, Kitahara T, Takimoto Y, et al. Functional expression of TRPV1 and TRPA1 in rat vestibular ganglia. Neurosci Lett. 2013;552:929–7. 10.1016/j.neulet.2013.07.019
34. Yang X. Aroma constituents and alkylamides of red and green huajiao (Zanthoxylum bungeanum and Zanthoxylum schinifolium). J Agric Food Chem. 2008;56(5):16891–696. 10.1021/jf0728101
35. Wang X, Shi XD, Li LF, Zhou P, Shen YW, Song QK. Prevalence and clinical features of adult atopic dermatitis in tertiary hospitals of China. Medicine. 2017;96(11):e6317. 10.1097/MD.0000000000006317